Kiniksa Pharmaceuticals International (KNSA) FCF Margin Growth (1y) (2022 - 2026)
Kiniksa Pharmaceuticals International (KNSA) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn | 123.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 123.00 |
| Mar 31, 2026 | 567.00 |
| Dec 31, 2025 | 1,172.00 |
| Sep 30, 2025 | 2,054.00 |
| Jun 30, 2025 | 1,665.00 |
| Mar 31, 2025 | 1,690.00 |
| Dec 31, 2024 | 639.00 |
| Sep 30, 2024 | -2,734.00 |
| Jun 30, 2024 | 659.00 |
| Mar 31, 2024 | 285.00 |
| Dec 31, 2023 | -111.00 |
| Sep 30, 2023 | -3,726.00 |
| Jun 30, 2023 | 2,304.00 |
| Mar 31, 2023 | 10,384.00 |
| Dec 31, 2022 | 12,060.00 |
| Sep 30, 2022 | 30,475.00 |
| Jun 30, 2022 | 47,563.00 |